Head to head
Clover Health vs UnitedHealth
Side-by-side on the measures that matter, with a plain-English read. Full detail: CLOV · UNH
CLOV
Clover Health
4.56-0.87%
1-year price shape — +69% over the period
Quant Rating B · 90/100
vs
UNH
UnitedHealth
375.98-0.09%
1-year price shape — +5% over the period
Quant Rating C · 47/100
1-year performance, rebased to 100
UnitedHealth edges it on the scoreable measures. UnitedHealth pays the highest dividend yield; UnitedHealth earns the most per share.
| CLOV | UNH | |
|---|---|---|
| Snapshot | ||
| Sector | Healthcare Plans | Healthcare Plans |
| Last price | 4.56 | 375.98 |
| Change today | -0.87% | -0.09% |
| 1-year return | +68.9% | +5.5% |
| Market cap | $2.42B | $337.48B |
| 52-week range | 1.58 – 5.59 | 252.95 – 458.79 |
| Valuation | ||
| P/E (TTM) | -91.20 | 24.16 |
| P/E percentile, own 5-yr range | 1st | 46th |
| P/B | 6.44 | 3.43 |
| Dividend yield | 0.00% | 2.38% |
| Profitability & growth | ||
| EPS (TTM) | -0.17 | 13.23 |
| Net profit (TTM) | $-90.30M | $11.88B |
| Revenue (TTM) | $2.48B | $450.13B |
| Revenue growth (YoY) | +55.6% | +0.4% |
| Gross margin | 18.6% | 19.5% |
| Operating margin | -0.7% | 4.8% |
| Net margin | -0.7% | 3.1% |
| Free cash flow (TTM) | $74.21M | $23.62B |
| Ownership & sentiment | ||
| Institutional ownership | 28.2% | 89.3% |
| Insider activity (12mo) | 4 buy / 44 sell | 46 buy / 4 sell |
| Short interest (% of float) | 4.4% | 1.5% |
| Analyst consensus | 67% buy / 33% hold (3) | 81% buy / 19% hold (21) |
| Analyst price target | $6 (+21%) | $487 (+30%) |
| StockVane view | ||
| StockVane Quant Rating | B (90) | C (47) |
| Company | ||
| Employees | 724 | 390,000 |
| Founded | 2014 | -- |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.